20 May 2013
Keywords: isis, lilly, extend, antisense, accord, california, usa-based
Article | 15 August 2005
California, USA-based Isis Pharmaceuticals has extended its antisense drug discovery collaboration with US drug major Eli Lilly.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 August 2005
17 May 2013
© 2013 thepharmaletter.com